An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002) by Mark H. Gotfried, Carlos E. Girod, Danielle Antin-Ozerkis, Tracy Burgess, Indiana Strombom, John L. Stauffer, Klaus-Uwe Kirchgaessler, Maria L. Padilla

Subjects: Get full text

No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis by Elisabeth Bendstrup, Charlotte Hyldgaard, Mads Agerbæk, Charlotte U. Andersen, Ole Hilberg

Subjects: Get full text

Evaluation of the efficacy of pirfenidone in progressive chronic hypersensitivity pneumonitis by Eman Shebl, Tarek Hamdy

Subjects: Get full text

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy by Yusuke Kurita, Jun Araya, Shunsuke Minagawa, Hiromichi Hara, Akihiro Ichikawa, Nayuta Saito, Tsukasa Kadota, Kazuya Tsubouchi, Nahoko Sato, Masahiro Yoshida, Kenji Kobayashi, Saburo Ito, Yu Fujita, Hirofumi Utsumi, Haruhiko Yanagisawa, Mitsuo Hashimoto, Hiroshi Wakui, Yutaka Yoshii, Takeo Ishikawa, Takanori Numata, Yumi Kaneko, Hisatoshi Asano, Makoto Yamashita, Makoto Odaka, Toshiaki Morikawa, Katsutoshi Nakayama, Kazuyoshi Kuwano

Subjects: Get full text

Comparative study between pirfenidone and traditional drugs in treatment of idiopathic pulmonary fibrosis by Ramadan M Nafee, Waheed M Shoman, Mohammed M.N AboZaid, Dalia A El Wahed

Subjects: Get full text

Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes by Hanaa Wanas, Hossein M. Elbadawy, Mohannad A. Almikhlafi, Amany E. Hamoud, Eid N. Ali, Amr M. Galal

Subjects: Get full text

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study by Myung Jin Song, Sang Hoon Lee, Ji Ye Jung, Young Ae Kang, Moo Suk Park, Young Sam Kim, Joon Chang, Song Yee Kim

Subjects: Get full text

Topical Pirfenidone-Loaded Liposomes Ophthalmic Formulation Reduces Haze Development after Corneal Alkali Burn in Mice by Carlos Daniel Diaz-Palomera, Isaac Alejandro Vidal-Paredes, Jose Navarro-Partida, Margarita Cid-Hernandez, Luis Carlos Rosales-Rivera, Ricardo De la Rosa-Bibiano, Hugo Christian Monroy-Ramirez, Arturo Santos, Juan Armendariz-Borunda

Subjects: Get full text

Preparation of Novel Pirfenidone Microspheres for Lung-Targeted Delivery: In vitro and in vivo Study [Retraction] by Li D, Gong L

Subjects: “…pirfenidone…”
Get full text

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic rev... by James Patrick Finnerty, Aravind Ponnuswamy, Prosjenjit Dutta, Ammar Abdelaziz, Hafiz Kamil

Subjects: Get full text

New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring? by Cristodor PL, Nechifor A, Fotea S, Nadasdy T, Bahloul Y, Nicolescu AC, Tatu AL

Subjects: Get full text

Pirfenidone improves survival in IPF: results from a real-life study by George A. Margaritopoulos, Athina Trachalaki, Athol U. Wells, Eirini Vasarmidi, Eleni Bibaki, George Papastratigakis, Stathis Detorakis, Nikos Tzanakis, Katerina M. Antoniou

Subjects: Get full text

TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation by Jung Eun Baik, Hyeung Ju Park, Raghu P. Kataru, Ira L. Savetsky, Catherine L. Ly, Jinyeon Shin, Elizabeth M. Encarnacion, Michele R. Cavali, Mark G. Klang, Elyn Riedel, Michelle Coriddi, Joseph H. Dayan, Babak J. Mehrara

Subjects: Get full text

Reactivation pulmonary tuberculosis in two patients treated with pirfenidone by Mohammad Khan, Majed Alghamdi, Hamdan AL-Jahdali

Subjects: Get full text

Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis by Paolo Giannoni, Marco Grosso, Giuseppina Fugazza, Mario Nizzari, Maria Cristina Capra, Rita Bianchi, Roberto Fiocca, Sandra Salvi, Fabrizio Montecucco, Maria Bertolotto, Franco Fais, Mario Salio, Emanuela Barisione, Daniela de Totero

Subjects: Get full text

Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life... by Olcay Aycicek, Serra Keskin, Muhammed Haciosmanoglu, Funda Oztuna, Yilmaz Bulbul, Tevfik Ozlu

Subjects: Get full text

Pirfenidone use in fibrotic diseases: What do we know so far? by Aldo Torre, Froylan David Martínez‐Sánchez, Sofía Mercedes Narvaez‐Chávez, Mariana Ariel Herrera‐Islas, Carlos Alberto Aguilar‐Salinas, Jacqueline Córdova‐Gallardo

Subjects: Get full text

Perils with Pirfenidone and “the tuberculosis link” by Madhav H Hande, K Vishak Acharya, A Shreenivasa, Kashinath Nayak, S Arun

Subjects: Get full text

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis by Zarir F Udwadia, Jai B Mullerpattan, Canchi Balakrishnan, Luca Richeldi

Subjects: Get full text

Effects of Pirfenidone on Idiopathic Pulmonary Fibrosis Progression and Safety: Results of Multicenter Prospective Observational Study by Sergey Avdeev, Mikhail Ilkovich, Stanislav Terpigorev, Sergey Moiseev, Igor Tyurin

Subjects: “…pirfenidone…”
Get full text